KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Neoleukin Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Neoleukin Therapeutics Inc is NLTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Neoleukin Therapeutics Inc Stock?
Neoleukin Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Neoleukin Therapeutics Inc Stock?
Neoleukin Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Neoleukin Therapeutics Inc Stock.

What's the current price of Neoleukin Therapeutics Inc Stock?
As of the end of day on the Mar 15, 2024, the price of an Neoleukin Therapeutics Inc (NLTX) share was $3.49.

What is the 52-week high and low for Neoleukin Therapeutics Inc Stock?
The 52-week high for Neoleukin Therapeutics Inc Stock is $4.14 and the 52-week low is $0.610.

What is the market capitalization of Neoleukin Therapeutics Inc Stock?
As of the Mar 15, 2024, the market capitalization of Neoleukin Therapeutics Inc is 8.2M.

When is the next earnings date for Neoleukin Therapeutics Inc?
The upcoming earnings date for Neoleukin Therapeutics Inc is May 06, 2024.
Click to get the best stock tips daily for free!

About Neoleukin Therapeutics Inc

Neoleukin Therapeutics Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aqui... NLTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT